Approved comparison material connected to this topic.
6 total recordsSource comparisons are presented without a generated winner.
Standard Research Protocol 100–200mcg 200–300mcg 2–3× daily (6–8hr intervals) 200–300% 92–96% preserved Optimal balance of efficacy and receptor preservation. Replicates physiological pulse architecture withou…
The addition of a Drug Affinity Complex (DAC) to CJC-1295 extends its half-life from 30 minutes to 6–8 days by covalently binding the peptide to serum albumin. This modification allows once-weekly dosing but f…
Dose per injection 100mcg each peptide 200mcg each peptide 100–150mcg each Start at 100mcg, increase to 150–200mcg after week 2 if tolerated Frequency Once daily (pre-bed only) Twice daily (morning + pre-bed) …
Typical Research Dose 200mcg per injection 100–200mcg per injection CJC amplifies amplitude; Ipamorelin triggers the pulse. Synergy requires both Dosing Frequency 2x daily (morning + pre-sleep) Aligns with nat…
GH Pulse Frequency 1 amplified pulse per 24hr 2 amplified pulses per 24hr Sustained elevation (non-pulsatile) Natural pulsatility preserved Twice-daily pulsed mimics natural secretion; continuous blunts recept…
Standard Synergy 150mcg 250mcg 3×/week (M/W/F) General GH pulse optimisation without daily commitment Ideal starting point. Preserves receptor sensitivity while delivering measurable synergy. Best for research…